28Sep 2022
Targeting senescence as an anti‐cancer therapy

Targeting senescence as an anti‐cancer therapy

Cellular senescence is a stress response elicited by different molecular insults. Senescence results in cell cycle exit and is characterised by multiple phenotypic changes, such as the production of a bioactive secretome. Senescence plays a paradoxical role in cancer. Induction of senescence limits cancer progression and contributes to therapy success, but lingering senescent cells fuel progression, recurrence, and metastasis. This review describes the intricate relation between senescence and cancer. Future challenges of “one-two punch” approaches include how to best monitor senescence in cancer patients to survey their efficacy effectively.

  • #oncology

Like

Save

Share